{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:47:19Z","timestamp":1793317639374,"version":"4.5.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In some observational studies, attention-deficit\/hyperactivity disorder has been linked to allergic diseases, but the findings are debatable. This study aimed to determine whether attention-deficit\/hyperactivity disorder (ADHD) is causally related to allergic asthma, allergic rhinitis, pollen allergy, allergic urticaria, and allergic conjunctivitis using the two-sample Mendelian Randomization (MR) approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We did a two-sample Mendelian randomization (MR) study, which chose single nucleotide polymorphisms (SNPs) that are highly associated with attention-deficit\/hyperactivity disorder (ADHD) levels from the Psychiatric Genomics Consortium (PGC) on 20,183 cases and 35,191 controls as our instruments. Outcomes datasets included genome-wide association study (GWAS) meta-analysis (<jats:italic>n<\/jats:italic>\u2009=\u20091,415,804). The summary statistics of outcome data were obtained from the FinnGen datasets including allergic asthma (10,877 cases and 180,942 controls), allergic rhinitis (8,430 cases and 298,829 controls), pollen allergy (4555cases and 301,734 controls), allergic urticaria (1792 cases and 299,491 controls) and allergic conjunctivitis (15,567 cases and 293,587 controls). Inverse variance weighted, MR-Egger, weighted median, were used to estimate the causal association between ADHD and allergic diseases. Cochran\u2019s Q test was used to quantify the heterogeneity of instrumental variables. MR-Egger intercept test, leave-one-out analysis, and the funnel plot were all used in sensitivity analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The Mendelian randomization (MR) analysis indicated that ADHD in inverse variance weighted [odds ratio (OR)\u2009=\u20091.0612; 95% confidence interval (CI):1.0192\u20131.1049; <jats:italic>p<\/jats:italic>\u2009=\u20090.0039] lightly increased the risk of allergic asthma. In MR sensitivity analyses of the weighted median, a similar association was found. But no evidence for an effect of ADHD on allergic asthma risk was found in additional methods: MR-Egger (OR\u2009=\u20090.9592, 95% CI: 0.8384\u20131.0974, <jats:italic>p<\/jats:italic>\u2009=\u20090.5457), and weighted median (OR: =1.0341, 95% CI: 0.9785\u20131.0929, <jats:italic>p<\/jats:italic>\u2009=\u20090.2330). Also, no strong evidence for an effect of ADHD on other allergic diseases (allergic rhinitis, pollen allergy, allergic urticaria, and allergic conjunctivitis) incidence was found using the inverse variance weighted (IVW) method, weighted median method, and MR-Egger regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although several studies have found a link between ADHD and allergic diseases, our findings do not support that ADHD could increase allergic diseases incidence. Randomized controlled trials or Mendelian randomization studies with larger samples are still needed to draw more precise conclusions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1185088","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T22:28:15Z","timestamp":1688596095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations between attention-deficit\/hyperactivity disorder and allergic diseases: a two-sample Mendelian randomization study"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiangyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41380-018-0116-3","article-title":"Treatment strategies for Adhd: an evidence-based guide to select optimal treatment","volume":"24","author":"Caye","year":"2019","journal-title":"Mol Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","article-title":"Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a Nationwide cohort study","volume":"385","author":"Dalsgaard","year":"2015","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-clinpsy-050817-084917","article-title":"Attention deficit hyperactivity disorder (Adhd): controversy, developmental mechanisms, and multiple levels of analysis","volume":"14","author":"Hinshaw","year":"2018","journal-title":"Annu Rev Clin Psychol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jaac.2021.05.019","article-title":"Review: adult outcome as seen through controlled prospective follow-up studies of children with attention-deficit\/hyperactivity disorder followed into adulthood","volume":"61","author":"Cherkasova","year":"2022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/00004583-199407000-00010","article-title":"Associations between childhood asthma and Adhd: issues of psychiatric comorbidity and Familiality","volume":"33","author":"Biederman","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","article-title":"Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder","volume":"51","author":"Demontis","year":"2019","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators","volume":"178","author":"Pierce","year":"2013","journal-title":"Am J Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","article-title":"Phenoscanner: a database of human genotype\u2013phenotype associations","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the Mr-egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1037\/0033-2909.106.3.434","article-title":"Attention deficit disorder and allergy: a neurochemical model of the relation between the illnesses","volume":"106","author":"Marshall","year":"1989","journal-title":"Psychol Bull"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-244X-11-128","article-title":"Adult attention deficit hyperactivity disorder is associated with asthma","volume":"11","author":"Fasmer","year":"2011","journal-title":"BMC Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/sj.bjp.0704758","article-title":"Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD","volume":"136","author":"Birrell","year":"2002","journal-title":"Br J Pharmacol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1185088\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T22:28:21Z","timestamp":1688596101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1185088\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":15,"alternative-id":["10.3389\/fpsyt.2023.1185088"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1185088","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"article-number":"1185088"}}